Celyad Oncology SA (EBR:CYAD)

Celyad Oncology Revenue

Celyad Oncology had revenue of 14.00K EUR in the half year ending June 30, 2025, a decrease of -68.18%. This brings the company's revenue in the last twelve months to 186.00K, up 158.33% year-over-year. In the year 2024, Celyad Oncology had annual revenue of 186.00K with 82.35% growth.

• Revenue: 186.00K
• Revenue Growth: +158.33%
• P/S Ratio: 44.52
• Revenue / Employee: 10.33K
• Employees: 19
• Market Cap: 8.28M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	186.00K	84.00K	82.35%
Dec 31, 2023	102.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	5.00K	-1.00K	-16.67%